Jeremie Girard
Plus aucun poste en cours
Profil
Jeremie Girard worked as a Director at Sanofi-Aventis Recherche et Développement SA and as a Member-Supervisory Board at Kiadis Pharma NV.
Anciens postes connus de Jeremie Girard
| Sociétés | Poste | Fin |
|---|---|---|
| KIADIS PHARMA N.V. | Director/Board Member | - |
Sanofi-Aventis Recherche et Développement SA
 Sanofi-Aventis Recherche et Développement SA Miscellaneous Commercial ServicesCommercial Services Sanofi-Aventis Recherche et Développement SA is a pharmaceutical company based in Chilly-Mazarin, France. Part of Sanofi, Sanofi-Aventis Recherche et Développement SA is a French company that focuses on delivering medicines and vaccines for millions of people around the world. The private company's R & D teams work closely with patient communities affected by rare hematological disorders to offer them effective and innovative therapeutic care. Find out more about rare hematological disorders in R&D. The company was founded in 1900. Lionel Joël Bascles has been the CEO of the company since 2018. | Director/Board Member | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Sanofi-Aventis Recherche et Développement SA
Sanofi-Aventis Recherche et Développement SA Miscellaneous Commercial ServicesCommercial Services Sanofi-Aventis Recherche et Développement SA is a pharmaceutical company based in Chilly-Mazarin, France. Part of Sanofi, Sanofi-Aventis Recherche et Développement SA is a French company that focuses on delivering medicines and vaccines for millions of people around the world. The private company's R & D teams work closely with patient communities affected by rare hematological disorders to offer them effective and innovative therapeutic care. Find out more about rare hematological disorders in R&D. The company was founded in 1900. Lionel Joël Bascles has been the CEO of the company since 2018. | Commercial Services |
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
